Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program (2010) (ISBN 0309151864) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine


• The Development of Medications for the Treatment of Opiate and Cocaine Addictions: Issues for the Government and Private Sector (1995) (ISBN 0309052440) Carolyn E. Fulco, Catharyn T. Liverman, and Laurence E. Earley, Editors; Committee to Study Medication Development and Research at the National Institute on Drug Abuse, Institute of Medicine


• Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (2012) (ISBN 0309261163) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (2012) (ISBN 0309253152) Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• The Future of Drug Safety: Promoting and Protecting the Health of the Public (2007) (ISBN 0309103045) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Transforming Clinical Research in the United States: Challenges and Opportunities: Workshop Summary (2010) (ISBN 0309153328) Rebecca English, Yeonwoo Lebovitz, and Robert Griffin, authors; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Report (2006) (ISBN 030910078X) Committee on Clinical Trial Registries


• Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (2007) (ISBN 030910386X) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors


• Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary (2012) (ISBN 0309220645) Margie Patlak, Erin Balogh, and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine


• Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary (2009) (ISBN 0309128676) Margie Patlak, Sharyl Nass, and Christine Micheel, Rapporteurs, Institute of Medicine


• Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval: The National Cancer Institute and the Food and Drug Administration (2005) (ISBN 0309096391)


• The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary (2010) (ISBN 0309150248) Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, Rapporteurs; Forum on Medical and Public Health Preparedness for Catastrophic Events; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Orphans and Incentives: Developing Technology to Address Emerging Infections (1997) (ISBN 0309059410) Polly F. Harrison and Joshua Lederberg, Editors; Forum on Emerging Infections, Institute of Medicine


• Extending the Spectrum of Precompetitive Collaboration in Oncology Research: Workshop Summary (2010) (ISBN 0309156548) Margie Patlak, Sharyl J. Nass, and Erin Balogh, Rapporteurs; Institute of Medicine